miscript rt kit Search Results


96
Qiagen miscript sybr green pcr kit
Miscript Sybr Green Pcr Kit, supplied by Qiagen, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/miscript+rt+kit/UCP+SYBR+Green+PCR+Kit/10__1074_slash_jbc__m115__679696-62-35-40
Average 96 stars, based on 1 article reviews
miscript sybr green pcr kit - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

96
Qiagen reverse transcription kit
Reverse Transcription Kit, supplied by Qiagen, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/miscript+rt+kit/QuantiNova+Reverse+Transcription+Kit/pm36114541-51-10-17
Average 96 stars, based on 1 article reviews
reverse transcription kit - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

99
Qiagen miscript mirna pcr system
Miscript Mirna Pcr System, supplied by Qiagen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/miscript+rt+kit/miRNeasy+Mini+Kit/pmc05766467-65-11-42
Average 99 stars, based on 1 article reviews
miscript mirna pcr system - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

97
Qiagen miscript single cell qpcr kit
Fig. 6 Targeting rs2431697 intervenes with the activation of the interferon pathway by modulating miR-146a expression. a–d <t>RT-qPCR</t> analysis of interferon-inducible gene expression in U-937 WT and deletion clones after treating with Interferon-α (IFIT1: **P = 0.0067, **IFIT3: P = 0.0027, **OAS1: P = 0.0066, ***IFI44: P = 0.0003) (n = 6, replicates represent unique biological clone replicates). e Flow scheme of inhibiting SLE IFN pathway by CRISPR activation (CRIPSRa) approach. f RT-qPCR analysis of Pri-miR-146a expression in SLE patients’ PBMCs after treating with the CRISPRa system targeting the rs2431697 locus, *P = 0.0204 (n = 9, replicates represent biological samples from unique individuals). g CRISPRa therapy decreases the IFN score of SLE patients’ PBMCs based on sgRNAs targeting the rs2431697 site, *P = 0.0158 (n = 9, replicates represent biological samples from unique individuals). Data are represented as mean ± SEM, and P-values are calculated using unpaired two-tailed Student’s t-test (a–d) and paired two-tailed Student’s test (f, g). *P < 0.05; **P < 0.01; ***P < 0.001.
Miscript Single Cell Qpcr Kit, supplied by Qiagen, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/miscript+rt+kit/Cell+Lysis+Solution/pm33420081-403-5-11
Average 97 stars, based on 1 article reviews
miscript single cell qpcr kit - by Bioz Stars, 2026-10
97/100 stars
  Buy from Supplier

99
Qiagen miscript ii rt kit
Fig. 6 Targeting rs2431697 intervenes with the activation of the interferon pathway by modulating miR-146a expression. a–d <t>RT-qPCR</t> analysis of interferon-inducible gene expression in U-937 WT and deletion clones after treating with Interferon-α (IFIT1: **P = 0.0067, **IFIT3: P = 0.0027, **OAS1: P = 0.0066, ***IFI44: P = 0.0003) (n = 6, replicates represent unique biological clone replicates). e Flow scheme of inhibiting SLE IFN pathway by CRISPR activation (CRIPSRa) approach. f RT-qPCR analysis of Pri-miR-146a expression in SLE patients’ PBMCs after treating with the CRISPRa system targeting the rs2431697 locus, *P = 0.0204 (n = 9, replicates represent biological samples from unique individuals). g CRISPRa therapy decreases the IFN score of SLE patients’ PBMCs based on sgRNAs targeting the rs2431697 site, *P = 0.0158 (n = 9, replicates represent biological samples from unique individuals). Data are represented as mean ± SEM, and P-values are calculated using unpaired two-tailed Student’s t-test (a–d) and paired two-tailed Student’s test (f, g). *P < 0.05; **P < 0.01; ***P < 0.001.
Miscript Ii Rt Kit, supplied by Qiagen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/miscript+rt+kit/RNase+A/pmc07716711-83-5-9
Average 99 stars, based on 1 article reviews
miscript ii rt kit - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

97
Qiagen miscript reverse transcription kit
Fig. 6 Targeting rs2431697 intervenes with the activation of the interferon pathway by modulating miR-146a expression. a–d <t>RT-qPCR</t> analysis of interferon-inducible gene expression in U-937 WT and deletion clones after treating with Interferon-α (IFIT1: **P = 0.0067, **IFIT3: P = 0.0027, **OAS1: P = 0.0066, ***IFI44: P = 0.0003) (n = 6, replicates represent unique biological clone replicates). e Flow scheme of inhibiting SLE IFN pathway by CRISPR activation (CRIPSRa) approach. f RT-qPCR analysis of Pri-miR-146a expression in SLE patients’ PBMCs after treating with the CRISPRa system targeting the rs2431697 locus, *P = 0.0204 (n = 9, replicates represent biological samples from unique individuals). g CRISPRa therapy decreases the IFN score of SLE patients’ PBMCs based on sgRNAs targeting the rs2431697 site, *P = 0.0158 (n = 9, replicates represent biological samples from unique individuals). Data are represented as mean ± SEM, and P-values are calculated using unpaired two-tailed Student’s t-test (a–d) and paired two-tailed Student’s test (f, g). *P < 0.05; **P < 0.01; ***P < 0.001.
Miscript Reverse Transcription Kit, supplied by Qiagen, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/miscript+rt+kit/Reverse+transcriptase/pm28753793-80-7-11
Average 97 stars, based on 1 article reviews
miscript reverse transcription kit - by Bioz Stars, 2026-10
97/100 stars
  Buy from Supplier

99
Qiagen rnase free water
Fig. 6 Targeting rs2431697 intervenes with the activation of the interferon pathway by modulating miR-146a expression. a–d <t>RT-qPCR</t> analysis of interferon-inducible gene expression in U-937 WT and deletion clones after treating with Interferon-α (IFIT1: **P = 0.0067, **IFIT3: P = 0.0027, **OAS1: P = 0.0066, ***IFI44: P = 0.0003) (n = 6, replicates represent unique biological clone replicates). e Flow scheme of inhibiting SLE IFN pathway by CRISPR activation (CRIPSRa) approach. f RT-qPCR analysis of Pri-miR-146a expression in SLE patients’ PBMCs after treating with the CRISPRa system targeting the rs2431697 locus, *P = 0.0204 (n = 9, replicates represent biological samples from unique individuals). g CRISPRa therapy decreases the IFN score of SLE patients’ PBMCs based on sgRNAs targeting the rs2431697 site, *P = 0.0158 (n = 9, replicates represent biological samples from unique individuals). Data are represented as mean ± SEM, and P-values are calculated using unpaired two-tailed Student’s t-test (a–d) and paired two-tailed Student’s test (f, g). *P < 0.05; **P < 0.01; ***P < 0.001.
Rnase Free Water, supplied by Qiagen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/miscript+rt+kit/RNase-Free+Water/10__1186_slash_s12645___025___00331___4-94-29-36
Average 99 stars, based on 1 article reviews
rnase free water - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

96
Bio-Rad miscript ii rt kit
Fig. 6 Targeting rs2431697 intervenes with the activation of the interferon pathway by modulating miR-146a expression. a–d <t>RT-qPCR</t> analysis of interferon-inducible gene expression in U-937 WT and deletion clones after treating with Interferon-α (IFIT1: **P = 0.0067, **IFIT3: P = 0.0027, **OAS1: P = 0.0066, ***IFI44: P = 0.0003) (n = 6, replicates represent unique biological clone replicates). e Flow scheme of inhibiting SLE IFN pathway by CRISPR activation (CRIPSRa) approach. f RT-qPCR analysis of Pri-miR-146a expression in SLE patients’ PBMCs after treating with the CRISPRa system targeting the rs2431697 locus, *P = 0.0204 (n = 9, replicates represent biological samples from unique individuals). g CRISPRa therapy decreases the IFN score of SLE patients’ PBMCs based on sgRNAs targeting the rs2431697 site, *P = 0.0158 (n = 9, replicates represent biological samples from unique individuals). Data are represented as mean ± SEM, and P-values are calculated using unpaired two-tailed Student’s t-test (a–d) and paired two-tailed Student’s test (f, g). *P < 0.05; **P < 0.01; ***P < 0.001.
Miscript Ii Rt Kit, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/miscript+rt+kit/Bio-Rad+Protein+Assay+Kit+II/pmc12650977-119-6-24
Average 96 stars, based on 1 article reviews
miscript ii rt kit - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

99
Illumina Inc fc 131 1096 miscript ii rt kit qiagen
Fig. 6 Targeting rs2431697 intervenes with the activation of the interferon pathway by modulating miR-146a expression. a–d <t>RT-qPCR</t> analysis of interferon-inducible gene expression in U-937 WT and deletion clones after treating with Interferon-α (IFIT1: **P = 0.0067, **IFIT3: P = 0.0027, **OAS1: P = 0.0066, ***IFI44: P = 0.0003) (n = 6, replicates represent unique biological clone replicates). e Flow scheme of inhibiting SLE IFN pathway by CRISPR activation (CRIPSRa) approach. f RT-qPCR analysis of Pri-miR-146a expression in SLE patients’ PBMCs after treating with the CRISPRa system targeting the rs2431697 locus, *P = 0.0204 (n = 9, replicates represent biological samples from unique individuals). g CRISPRa therapy decreases the IFN score of SLE patients’ PBMCs based on sgRNAs targeting the rs2431697 site, *P = 0.0158 (n = 9, replicates represent biological samples from unique individuals). Data are represented as mean ± SEM, and P-values are calculated using unpaired two-tailed Student’s t-test (a–d) and paired two-tailed Student’s test (f, g). *P < 0.05; **P < 0.01; ***P < 0.001.
Fc 131 1096 Miscript Ii Rt Kit Qiagen, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/miscript+rt+kit/Nextera+XT+DNA+Library+Preparation+Kit/10__2139_slash_ssrn__4020517-231-146-144
Average 99 stars, based on 1 article reviews
fc 131 1096 miscript ii rt kit qiagen - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

Image Search Results


Fig. 6 Targeting rs2431697 intervenes with the activation of the interferon pathway by modulating miR-146a expression. a–d RT-qPCR analysis of interferon-inducible gene expression in U-937 WT and deletion clones after treating with Interferon-α (IFIT1: **P = 0.0067, **IFIT3: P = 0.0027, **OAS1: P = 0.0066, ***IFI44: P = 0.0003) (n = 6, replicates represent unique biological clone replicates). e Flow scheme of inhibiting SLE IFN pathway by CRISPR activation (CRIPSRa) approach. f RT-qPCR analysis of Pri-miR-146a expression in SLE patients’ PBMCs after treating with the CRISPRa system targeting the rs2431697 locus, *P = 0.0204 (n = 9, replicates represent biological samples from unique individuals). g CRISPRa therapy decreases the IFN score of SLE patients’ PBMCs based on sgRNAs targeting the rs2431697 site, *P = 0.0158 (n = 9, replicates represent biological samples from unique individuals). Data are represented as mean ± SEM, and P-values are calculated using unpaired two-tailed Student’s t-test (a–d) and paired two-tailed Student’s test (f, g). *P < 0.05; **P < 0.01; ***P < 0.001.

Journal: Nature communications

Article Title: SLE non-coding genetic risk variant determines the epigenetic dysfunction of an immune cell specific enhancer that controls disease-critical microRNA expression.

doi: 10.1038/s41467-020-20460-1

Figure Lengend Snippet: Fig. 6 Targeting rs2431697 intervenes with the activation of the interferon pathway by modulating miR-146a expression. a–d RT-qPCR analysis of interferon-inducible gene expression in U-937 WT and deletion clones after treating with Interferon-α (IFIT1: **P = 0.0067, **IFIT3: P = 0.0027, **OAS1: P = 0.0066, ***IFI44: P = 0.0003) (n = 6, replicates represent unique biological clone replicates). e Flow scheme of inhibiting SLE IFN pathway by CRISPR activation (CRIPSRa) approach. f RT-qPCR analysis of Pri-miR-146a expression in SLE patients’ PBMCs after treating with the CRISPRa system targeting the rs2431697 locus, *P = 0.0204 (n = 9, replicates represent biological samples from unique individuals). g CRISPRa therapy decreases the IFN score of SLE patients’ PBMCs based on sgRNAs targeting the rs2431697 site, *P = 0.0158 (n = 9, replicates represent biological samples from unique individuals). Data are represented as mean ± SEM, and P-values are calculated using unpaired two-tailed Student’s t-test (a–d) and paired two-tailed Student’s test (f, g). *P < 0.05; **P < 0.01; ***P < 0.001.

Article Snippet: This assay was performed with miScript Single Cell qPCR Kit (331055, Qiagen) according to the manufacturer’s instructions.

Techniques: Activation Assay, Expressing, Quantitative RT-PCR, Gene Expression, Clone Assay, CRISPR, Two Tailed Test